Johnson Financial Statements From 2010 to 2024
| JNJB34 Stock | BRL 62.18 0.32 0.51% |
Check Johnson Johnson financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Johnson Johnson's main balance sheet or income statement drivers, such as , as well as many indicators such as . Johnson financial statements analysis is a perfect complement when working with Johnson Johnson Valuation or Volatility modules.
Johnson |
Johnson Johnson Company Return On Asset Analysis
Johnson Johnson's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Johnson Johnson Return On Asset | 0.0881 |
Most of Johnson Johnson's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Johnson Johnson has a Return On Asset of 0.0881. This is 101.01% lower than that of the Healthcare sector and 92.34% lower than that of the Drug Manufacturers - Major industry. The return on asset for all Brazil stocks is 162.93% lower than that of the firm.
Johnson Johnson Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Johnson Johnson's current stock value. Our valuation model uses many indicators to compare Johnson Johnson value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Johnson Johnson competition to find correlations between indicators driving Johnson Johnson's intrinsic value. More Info.Johnson Johnson is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Johnson Johnson is roughly 2.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Johnson Johnson by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Johnson Johnson's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Johnson Johnson Financial Statements
Johnson Johnson stakeholders use historical fundamental indicators, such as Johnson Johnson's revenue or net income, to determine how well the company is positioned to perform in the future. Although Johnson Johnson investors may analyze each financial statement separately, they are all interrelated. For example, changes in Johnson Johnson's assets and liabilities are reflected in the revenues and expenses on Johnson Johnson's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Johnson Johnson. Please read more on our technical analysis and fundamental analysis pages.
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. The company was incorporated in 1887 and is based in New Brunswick, New Jersey. JOHNSON DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 135100 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out the analysis of Johnson Johnson Correlation against competitors. For information on how to trade Johnson Stock refer to our How to Trade Johnson Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..